N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia.
Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia.
Molecules. 2018 Mar 17;23(3):679. doi: 10.3390/molecules23030679.
An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
在治疗肿瘤和神经退行性疾病方面,一个重要的任务是寻找新的 DNA 修复系统酶抑制剂。酪氨酸-DNA 磷酸二酯酶 1(Tdp1)是参与修复拓扑异构酶 I 抑制剂引起的 DNA 损伤的 DNA 修复系统酶之一。因此,降低 Tdp1 的活性可以提高目前使用的抗癌药物的疗效。我们在这里描述了一类新的基于胆酸支架的半合成小分子 Tdp1 抑制剂,这些抑制剂最初是通过虚拟筛选发现的。研究了胆酸的官能团(甾体骨架中的羟基和乙酰氧基以及侧链中的酰胺片段)对抑制活性的影响。体外研究表明,半合成衍生物具有有效抑制 Tdp1 的能力,IC 高达 0.29µM。此外,当配体对接进入 Tdp1 酶的活性位点时,实现了极好的拟合。